Technical420 Site Search

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), provides 2019 calendar operational and corporate highlights. The Company has made significant progress in the markets it operates. Along with internal growth, Chemesis has made significant acquisitions and has become a multi-state operator with vertically integrated operations. The Company’s calendar…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce it has completed installation of VividGro LED lighting and environment controls at its Natural Ventures cultivation facility in Puerto Rico. The completion of the previously announced partnership allowed the Company to double its cultivation area and was able to significantly…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that its subsidiary, Natural Ventures PR LLC (“Natural Ventures”), has entered into an agreement to purchase (the “Acquisition”) three cannabis dispensary operations (the “Dispensaries”) in Puerto Rico from Caribbean Green LLC (“Caribbean Green”) in exchange for $1.3 million USD…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, in conjunction with First Medical Cannabis LLC, (“First Medical”) through its previously announced partnership, has received one of the first hemp cultivation and processing licenses in Puerto Rico. The…

Last month, we published an update on Chemesis International Inc. (CSI.CN) (CADMF) which has been laser focused on the US cannabis market and this is an opportunity to put on your radar. 2019 has been a banner year for the US cannabis company and we are favorable on the way…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has completed the installation, permitting, and testing phase of its QuickStrip™ oral thin strip production equipment. The Company has completed the previously announced commercialization strategy, and has begun accepting…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces Happy Tea products to be carried across Chemesis’ GSRX retail dispensaries in Puerto Rico and California by September 2019. This announcement builds on the previously announced $4,000,000 USD purchase order and the partnership to develop and manufacture new products. Chemesis will manufacture and carry Happy…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is pleased to announce that it has completed its previously announced transaction  to acquire a controlling interest in GSRX Industries Inc. (“GSRX”) (OTCQB: GSRX) (the “Acquisition”), pursuant to which  the Company has acquired from certain former GSRX shareholders (the…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has received an initial purchase order for $1,100,000 USD for manufacturing CBD products. The purchase order is for CBD products that will be shipped to the United Kingdom (“UK”). These products include cartridges, tinctures, sprays, shots and other…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA), announces that it will begin to manufacture, package and distribute its own line of tobacco-free smokeless cannabis and hemp derived chew with initial launch and commercialization in the United States, Puerto Rico and Canada. The Company continues to build out a unique portfolio of…